71^st BPSC Mains

Approach: Introduce bioterrorism as a rising global threat and BWC as core prevention mechanism. In the body, assess BWC’s strengths and weaknesses—no verification regime, dual-use tech, non-compliance; examine enforcement gaps. In the conclusion, suggest India strengthen surveillance, biosafety laws, and international cooperation under BWC.

Answer: The Biological Weapons Convention (1975) is a landmark multilateral disarmament treaty that prohibits the development, production, acquisition, and stockpiling of biological and toxin weapons. However, in the context of rising global health security threats and increasing risks from non-state actors, the effectiveness of the BWC in preventing bioterrorism has come under critical scrutiny. India, at the BWC’s 50th commemoration, emphasized that the world remains inadequately prepared for this threat.

Effectiveness of the BWC in Prevention

The BWC serves as a foundational ethical and normative barrier against biological warfare, utilizing its General-Purpose Criterion (Article text I) to ban all biological agents or toxins that lack legitimate protective or prophylactic use.

• Normative Deterrence: The treaty established a global norm against the use of biological agents as Weapons of Mass Destruction (WMD), influencing the behavior of 184 State Parties.
• Domestic Implementation: State Parties, including India, have created robust national regulatory frameworks, such as the Weapons of Mass Destruction (WMD) Act, 2005, and export controls under the SCOMET list, to criminalize bioterrorism and control dual-use technologies domestically.

Challenges Hindering BWC Enforcement

Despite its normative success, the BWC’s enforcement is severely handicapped by structural gaps that undermine its effectiveness against contemporary threats.

• Absence of Verification Mechanism: The most critical gap is the lack of a formal compliance and verification protocol. Unlike the Chemical Weapons Convention (CWC) with its Organisation for the Prohibition of Chemical Weapons (OPCW), the BWC’s Implementation Support Unit lacks any inspection or enforcement powers, eroding global confidence.
• Dual-Use Dilemma: Advances in synthetic biology and genetic engineering create significant Dual-Use Research Risks. Research intended for vaccines or diagnostics can be misused by state or non-state actors to create more potent pathogens, making detection and attribution difficult.
• Bioterrorism and Non-State Actors: The BWC is a treaty among states. It offers limited direct mechanisms to counter bioterrorism, which is typically perpetrated by non-state actors drawn to the low-cost, high-impact potential of biological agents. The COVID -19 pandemic exposed the global vulnerability to rapidly spreading pathogens, whether natural or deliberate.

Strengthening India’s National Preparedness

India, with its advanced biotechnology sector and significant population vulnerability, must strengthen its national preparedness under the BWC framework.

• Comprehensive National Biosecurity Framework: India must operationalize its proposed comprehensive framework covering high-risk biological agents, mandatory domestic reporting of suspicious research, and established incident-management protocols to ensure swift response capability.
• Bio-Forensics and Attribution: Invest heavily in scientific and technical capacity for Bio-Forensics to accurately trace the source of outbreaks. This deters deliberate misuse by increasing the likelihood of attribution.
• Global South Focus: Champion the proposal to strengthen the BWC’s Article VII Assistance Mechanism (as proposed with France) to facilitate timely aid, especially to vulnerable nations in the Global South, thereby building collective resilience against biological threats.

Conclusion

The BWC remains indispensable, but its effectiveness is constrained by its structural deficiencies in verification and oversight. To safeguard its national interests, India must not only maintain its strong domestic regulatory regime but also actively push for the multilateral strengthening of the BWC by addressing the verification gap and championing equitable access to vaccines and technology for all nations. A robust, internationally cooperative biosecurity system is the only defence against the borderless threat of bioterrorism.